Dr Bruce Joseph Siedlecki, MD | |
Mtn.home Aif Force Base, Mdos, Mtn. Home, ID 83647 | |
(208) 828-7567 | |
Not Available |
Full Name | Dr Bruce Joseph Siedlecki |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | Mtn.home Aif Force Base, Mtn. Home, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285628156 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MD25309 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Bruce Joseph Siedlecki, MD 1050 Nw Bluegrass Cir, Mtn Home, ID 83647-1544 Ph: (208) 828-7567 | Dr Bruce Joseph Siedlecki, MD Mtn.home Aif Force Base, Mdos, Mtn. Home, ID 83647 Ph: (208) 828-7567 |
News Archive
Patients with chronic myelogenous leukaemia resistant or intolerant to at least one second-generation tyrosine kinase inhibitor have a higher probability of achieving a response to the third-generation TKI ponatinib than to a further second-generation TKI, research indicates.
Nokia today announced the launch of Ovi Life Tools in China. Designed for the emerging markets, Ovi Life Tools offers a wide range of information services covering healthcare, agriculture, education and entertainment.
Pfizer Oncology will present data from across its portfolio, including results from long-term follow-up of Aromasin® (exemestane tablets) in a study of early breast cancer, updated study results from a Phase 3 study of Sutent® (sunitinib malate) in pancreatic neuroendocrine tumors (NET), and early-stage research of investigational agents PF-02341066 and figitumumab (CP-751,871) in patients with non-small cell lung cancer (NSCLC).
"Sixteen countries in West and Central Africa are in the throes of a measles outbreak, at a time when there is a shortfall in funding for vaccination campaigns against the disease, two U.N. agencies said in a joint statement on Thursday," Reuters AlertNet reports (Fominyen, 4/22).
Researchers at King's College London have discovered how one of the most common household painkillers works, which could pave the way for less harmful pain relief medications to be developed in the future.
› Verified 9 days ago